IL-10, a key effector regulatory cytokine in experimental autoimmune encephalomyelitis (Q35147380)

6 August 2017

1 reference

title

IL-10, a key effector regulatory cytokine in experimental autoimmune encephalomyelitis (English)

1 reference

experimental autoimmune encephalomyelitis

6 August 2017

0 references

3

Vijay K Kuchroo

1 reference

6 August 2017

Estelle Bettelli

1

1 reference

PubMed ID

12791309

6 August 2017

Lindsay B Nicholson

series ordinal

2

1 reference

6 August 2017

1 June 2003

1 reference

6 August 2017

Journal of Autoimmunity

1 reference

6 August 2017

20

1 reference

6 August 2017

4

1 reference

6 August 2017

265-267

1 reference

The T lymphocyte in experimental allergic encephalomyelitis

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2803%2900048-9

7 January 2021

Experimental autoimmune encephalomyelitis as a model of immune-mediated CNS disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2803%2900048-9

7 January 2021

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2803%2900048-9

7 January 2021

An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2803%2900048-9

7 January 2021

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2803%2900048-9

7 January 2021

Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2803%2900048-9

7 January 2021

IL-4 abrogates the inhibitory effect of IL-10 on the development of experimental allergic encephalomyelitis in SJL mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2803%2900048-9

7 January 2021

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2803%2900048-9

7 January 2021

Interleukin-10 and the interleukin-10 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2803%2900048-9

7 January 2021

Interleukin-10 prevents experimental allergic encephalomyelitis in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2803%2900048-9

7 January 2021

Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2803%2900048-9

7 January 2021

Different therapeutic outcomes in experimental allergic encephalomyelitis dependent upon the mode of delivery of IL-10: a comparison of the effects of protein, adenoviral or retroviral IL-10 delivery into the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2803%2900048-9

7 January 2021

IL-10 fails to abrogate experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2803%2900048-9

7 January 2021

Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2803%2900048-9

7 January 2021

Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2803%2900048-9

7 January 2021

An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2803%2900048-9

7 January 2021

Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2803%2900048-9

7 January 2021

Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2803%2900048-9

7 January 2021

Neonatal exposure to antigen primes the immune system to develop responses in various lymphoid organs and promotes bystander regulation of diverse T cell specificities.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2803%2900048-9

7 January 2021

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2803%2900048-9

7 January 2021

In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2803%2900048-9

7 January 2021

Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2803%2900048-9

7 January 2021

Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2803%2900048-9

7 January 2021

Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2803%2900048-9

7 January 2021

Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2803%2900048-9

7 January 2021

B cells regulate autoimmunity by provision of IL-10.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2803%2900048-9

7 January 2021

10.1016/S0896-8411(03)00048-9

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12791309